How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

2,191 results for

Echocardiogram in Congestive Heart Failure

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Chronic congestive heart failure

; a thorough history and physical examination should be obtained to identify cardiac and non-cardiac disorders or behaviours that might cause congestive heart failure or accelerate progression. The single most useful diagnostic test in the evaluation of patients is the comprehensive 2-dimensional echocardiogram coupled with Doppler flow studies. Measurement of B-type natriuretic peptide can be useful in the evaluation of patients at initial presentation. Interventions that have a proven beneficial impact (...) Chronic congestive heart failure Chronic congestive heart failure - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Chronic congestive heart failure Last reviewed: February 2019 Last updated: January 2019 Summary A complex clinical syndrome that can result from any structural or functional cardiac disorder that impairs the ability of the ventricle to fill with or eject blood. It is a major and growing public health

2019 BMJ Best Practice

2. Acute exacerbation of congestive heart failure

Acute exacerbation of congestive heart failure Acute exacerbation of congestive heart failure - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Acute exacerbation of congestive heart failure Last reviewed: February 2019 Last updated: October 2018 Summary Clinical syndrome of reduced cardiac output, tissue hypoperfusion, increased pulmonary pressure, and tissue congestion. Presents with dyspnoea, decreased exercise (...) tolerance, swelling of the legs, fatigue, and generalised weakness. Clinical diagnosis is supported by ancillary tests such as ECG, chest x-ray, B-type natriuretic peptide, and echocardiogram. In cases where echocardiographic images are suboptimal or when an unusual cause of heart failure is suspected, and for diagnosis of specific cardiomyopathies, other tests (e.g., cardiac catheterisation with haemodynamic measurements, computed tomography, and cardiac magnetic resonance imaging) are used. Diuretics

2018 BMJ Best Practice

3. Chronic congestive heart failure

; a thorough history and physical examination should be obtained to identify cardiac and non-cardiac disorders or behaviours that might cause congestive heart failure or accelerate progression. The single most useful diagnostic test in the evaluation of patients is the comprehensive 2-dimensional echocardiogram coupled with Doppler flow studies. Measurement of B-type natriuretic peptide can be useful in the evaluation of patients at initial presentation. Interventions that have a proven beneficial impact (...) Chronic congestive heart failure Chronic congestive heart failure - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Chronic congestive heart failure Last reviewed: February 2019 Last updated: January 2019 Summary A complex clinical syndrome that can result from any structural or functional cardiac disorder that impairs the ability of the ventricle to fill with or eject blood. It is a major and growing public health

2018 BMJ Best Practice

4. Acute exacerbation of congestive heart failure

Acute exacerbation of congestive heart failure Acute exacerbation of congestive heart failure - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Acute exacerbation of congestive heart failure Last reviewed: February 2019 Last updated: October 2018 Summary Clinical syndrome of reduced cardiac output, tissue hypoperfusion, increased pulmonary pressure, and tissue congestion. Presents with dyspnoea, decreased exercise (...) tolerance, swelling of the legs, fatigue, and generalised weakness. Clinical diagnosis is supported by ancillary tests such as ECG, chest x-ray, B-type natriuretic peptide, and echocardiogram. In cases where echocardiographic images are suboptimal or when an unusual cause of heart failure is suspected, and for diagnosis of specific cardiomyopathies, other tests (e.g., cardiac catheterisation with haemodynamic measurements, computed tomography, and cardiac magnetic resonance imaging) are used. Diuretics

2018 BMJ Best Practice

5. Echocardiogram in Congestive Heart Failure

Echocardiogram in Congestive Heart Failure Echocardiogram in Congestive Heart Failure Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 (...) Echocardiogram in Congestive Heart Failure Echocardiogram in Congestive Heart Failure Aka: Echocardiogram in Congestive Heart Failure , Echocardiogram in CHF , Echocardiogram in Systolic Dysfunction , Echocardiogram in Diastolic Dysfunction , E-A Wave Ratio , Measurement of Tau II. Indication Every patient with ! Distinguishes Identify underlying valve disease Identify underlying ischemic heart damage Quantify severity III. Assessment Chamber size (diastolic and end-systolic dimensions) Left Atrial

2018 FP Notebook

6. Bayesian Hemodynamics Model for Personalized Monitoring of Congestive Heart Failure Patients

Bayesian Hemodynamics Model for Personalized Monitoring of Congestive Heart Failure Patients Bayesian Hemodynamics Model for Personalized Monitoring of Congestive Heart Failure Patients - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more (...) studies before adding more. Bayesian Hemodynamics Model for Personalized Monitoring of Congestive Heart Failure Patients The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03575533 Recruitment Status : Recruiting First Posted

2018 Clinical Trials

7. Validating Left Ventricular Filling Pressure Measurements in Patients with Congestive Heart Failure: CardioMEMSâ„¢ Pulmonary Arterial Diastolic Pressure versus Left Atrial Pressure Measurement by Transthoracic Echocardiography (PubMed)

Validating Left Ventricular Filling Pressure Measurements in Patients with Congestive Heart Failure: CardioMEMSâ„¢ Pulmonary Arterial Diastolic Pressure versus Left Atrial Pressure Measurement by Transthoracic Echocardiography Routine ambulatory echocardiographic estimates of left ventricular (LV) filling pressures are not cost-effective and are occasionally fraught with anatomic, physiologic as well as logistical limitations. The use of implantable hemodynamic devices such as CardioMEMS Heart (...) Failure (HF) System has been shown to reduce HF-related readmission rates by remote monitoring of LV filling pressures. Little is known about the correlation between CardioMEMS and echocardiography-derived estimates of central hemodynamics.We performed a prospective, single-center study enrolling seventeen participants with New York Heart Association functional class II-III HF and preimplanted CardioMEMS sensor. Simultaneous CardioMEMS readings and a limited echocardiogram were performed at individual

Full Text available with Trip Pro

2018 Cardiology research and practice

8. V-LAPâ„¢ Left Atrium Monitoring systEm for Patients With Chronic sysTOlic & Diastolic Congestive heaRt Failure

V-LAPâ„¢ Left Atrium Monitoring systEm for Patients With Chronic sysTOlic & Diastolic Congestive heaRt Failure V-LAP™ Left Atrium Monitoring systEm for Patients With Chronic sysTOlic & Diastolic Congestive heaRt Failure - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (...) (100). Please remove one or more studies before adding more. V-LAP™ Left Atrium Monitoring systEm for Patients With Chronic sysTOlic & Diastolic Congestive heaRt Failure (VECTOR-HF) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov

2018 Clinical Trials

9. Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association

Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January (...) 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association , MD, Chair , MD, MS, FAHA, Co-Chair , MD , MD, PhD, FAHA , MD , MD , MD, MS , MD, MPH, FAHA , MD , MD, PhD, FAHA , and MD, FAHA MDOn behalf of the American Heart Association Council on Clinical Cardiology; Council

Full Text available with Trip Pro

2018 American Heart Association

10. Database queries for hospitalizations for acute congestive heart failure: flexible methods and validation based on set theory. (PubMed)

Database queries for hospitalizations for acute congestive heart failure: flexible methods and validation based on set theory. Electronic health records databases are increasingly used for identifying cohort populations, covariates, or outcomes, but discerning such clinical 'phenotypes' accurately is an ongoing challenge. We developed a flexible method using overlapping (Venn diagram) queries. Here we describe this approach to find patients hospitalized with acute congestive heart failure (CHF (...) zones. The acute CHF (presence/absence) outcome was based on expert chart review using a priori criteria.Among 79,091 hospitalizations, we reviewed 908. A query for any ICD-9 code for CHF had PPV 42.8% (SE 1.5%) for acute CHF and sensitivity 94.3% (1.3%). Primary diagnosis of 428 and BNP >500 pg/mL had PPV 90.4% (SE 2.4%) and sensitivity 28.8% (1.1%). PPV was <10% when there was no echocardiogram, no BNP, and no primary diagnosis. 'False positive' hospitalizations were for other heart disease, lung

Full Text available with Trip Pro

2017 Journal of the American Medical Informatics Association

11. Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress. (PubMed)

with acute respiratory distress. The patient's history, symptoms, physical exam, chest x-ray, and an echocardiogram were used to identify patients with congestive heart failure (CHF) from noncardiac causes of respiratory distress. Results are reported as mean+/-SD. Patients with CHF (n = 23) had BNP levels of 693.0+/-501.6 pg/ml, significantly higher than those of the group of patients with lung disease (n = 26), whose BNP was 45.2+/-64.0 pg/ml (p < 0.001). There was no significant difference in age (...) Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress. Plasma B-type natriuretic peptide (BNP) has been reported to be helpful in differentiating cardiac from pulmonary etiologies of dyspnea in adults. We investigated whether BNP concentration could be applied similarly in children with respiratory distress. BNP levels were measured using a rapid immunoassay in 49 infants and children presenting

2017 Pediatric Cardiology

12. Clinical and echocardiographic characteristics and outcomes in congestive heart failure at the Hospital of The State University of Haiti. (PubMed)

Clinical and echocardiographic characteristics and outcomes in congestive heart failure at the Hospital of The State University of Haiti. This study aimed to evaluate the clinical and epidemiologic profile of congestive heart failure at the principal free-care hospital in Haiti. Cardiovascular disease represents the most prevalent cause of admissions to the medical service of the University Hospital of the State of Haiti. No previous study has examined the demographics of congestive heart (...) , 76.7% of the patients were alive and well. Among those who died, mean survival time was 113 days. Readmission carried a poor prognosis.This congestive heart failure study from Haiti shows an unusually high proportion of young women, primarily due to peripartum cardiomyopathy. Ischemic cardiomyopathy is rare, as in Africa. Further study is warranted to address the particular problem of the high frequency of peripartum cardiomyopathy in this population.Copyright © 2016 Elsevier Inc. All rights

2016 American Heart Journal

13. Suspected New-Onset and Nonacute Heart Failure

. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation 2002;106:3068-72. 6. Merlo M, Pivetta A, Pinamonti B, et al. Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years. Eur J Heart Fail 2014;16:317-24. 7. Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004;292:344-50. 8. Centers for Disease (...) methods of pharmacologic stress testing and the potential advantages of new agents. J Nucl Med Technol 2009;37:14-25. 36. Roalfe AK, Mant J, Doust JA, et al. Development and initial validation of a simple clinical decision tool to predict the presence of heart failure in primary care: the MICE (Male, Infarction, Crepitations, Edema) rule. Eur J Heart Fail 2012;14:1000-8. 37. Kennedy S, Simon B, Alter HJ, Cheung P. Ability of physicians to diagnose congestive heart failure based on chest X-ray. J Emerg

2018 American College of Radiology

14. Evaluation and Management of Right-Sided Heart Failure

Evaluation and Management of Right-Sided Heart Failure Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 Free Access article Share on Jump to Free Access article (...) Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association , MD, Chair , MD, MS, FAHA, Co-Chair , MD , MD, PhD, FAHA , MD , MD , MD, MS , MD, MPH, FAHA , MD , MD, PhD, FAHA , and MD, FAHA MDOn behalf of the American Heart Association Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; and Council on Cardiovascular Surgery and Anesthesia Marvin A. Konstam , Michael S. Kiernan , Daniel Bernstein , Biykem Bozkurt , Miriam

Full Text available with Trip Pro

2018 International Society for Heart and Lung Transplantation

15. Management of chronic heart failure

are most useful rather than any of these in isolation. Basic early investigations are necessary to differentiate heart failure from other conditions and to provide prognostic information. Urinalysis, serum urea and creatinine tests may help to determine if there is kidney failure, since symptoms of kidney disease are similar to those of HF . Chest X-ray may indicate signs of HF such as cardiomegaly, pulmonary congestion or pleural effusion and also non-cardiac indications such as lung tumours which (...) -echocardiography. Patients with suspected chronic heart failure should receive a range of basic tests. The investigations chosen will vary depending on the presentation but should usually include a full blood count, fasting blood glucose, serum urea and electrolytes, urinalysis, thyroid function, electrocardiogram and chest X-ray. 3.1.2 FURTHER INVESTIGATIONS Following clinical examination and basic investigations, a decision must be made as to whether the patient should undergo an echocardiogram (see section

2016 SIGN

16. Acute and Chronic Heart Failure

myocardial infarction AMICA Atrial fibrillation Management In Congestive heart failure with Ablation ANP A-type natriuretic peptide ANS autonomic nervous system ARB angiotensin receptor blocker ARNI angiotensin receptor neprilysin inhibitor ARVC arrhythmogenic right ventricular cardiomyopathy AST aspartate aminotransferase ASV assisted servo-ventilation ATLAS Assessment of Treatment with Lisinopril And Survival ATTR transthyretin-mediated amyloidosis AV atrio-ventricular AVP arginine vasopressin b.i.d (...) CCU coronary care unit CHA 2 DS 2 -VASc Congestive heart failure or left ventricular dysfunction, Hypertension, Age ≥75 (doubled), Diabetes, Stroke (doubled)-Vascular disease, Age 65–74, Sex category (female) CHARM-Alternative Candesartan in heart failure assessment of reduction in mortality and morbidity CHARM-Added Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity CHARM-Preserved Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality

Full Text available with Trip Pro

2016 European Society of Cardiology

17. This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms.

- Administered Standardized format (CHQ-SAS) dyspnea score [ Time Frame: Week 0 and Week 12 ] Change from baseline to week 6 in exercise capacity as measured by the distance walked in 6 minutes [ Time Frame: Week 0 and Week 6 ] Change from baseline in Clinical Congestion Score at week 12 [ Time Frame: Week 0 and Week 12 ] Change from baseline in Patient Global Impression of Severity (PGI-S) of Heart Failure Symptoms at week 12 [ Time Frame: Week 0 and Week 12 ] Change from baseline in Patient Global (...) for patients without atrial fibrillation (AF), OR > 600 pg/ml for patients with AF, as analysed at the Central laboratory at Visit 1 Patients must have at least one of the following evidence of heart failure (HF): Structural heart disease (left atrial enlargement and/or left ventricular hypertrophy) documented by echocardiogram at Visit 1, OR Documented Hospitalization for Heart Failure (HHF) within 12 months prior to Visit 1 Consistent with prevailing CV guidelines, if oral diuretics are prescribed

2018 Clinical Trials

18. Drugs That May Cause or Exacerbate Heart Failure

Drugs That May Cause or Exacerbate Heart Failure Drugs That May Cause or Exacerbate Heart Failure | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share (...) on Jump to Free Access article Drugs That May Cause or Exacerbate Heart Failure A Scientific Statement From the American Heart Association , PharmD, MSPH, FAHA, Chair , PharmD , MD, MSc , MD , MD, MSCE , MB ChB, FAHA , PharmD , and PhD, ACNP-BC, FAHA MD, FAHA, Co-ChairOn behalf of the American Heart Association Clinical Pharmacology and Heart Failure and Transplantation Committees of the Council on Clinical Cardiology; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular

Full Text available with Trip Pro

2016 American Heart Association

19. Echocardiogram in Congestive Heart Failure

Echocardiogram in Congestive Heart Failure Echocardiogram in Congestive Heart Failure Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 (...) Echocardiogram in Congestive Heart Failure Echocardiogram in Congestive Heart Failure Aka: Echocardiogram in Congestive Heart Failure , Echocardiogram in CHF , Echocardiogram in Systolic Dysfunction , Echocardiogram in Diastolic Dysfunction , E-A Wave Ratio , Measurement of Tau II. Indication Every patient with ! Distinguishes Identify underlying valve disease Identify underlying ischemic heart damage Quantify severity III. Assessment Chamber size (diastolic and end-systolic dimensions) Left Atrial

2015 FP Notebook

20. The International Society for Heart and Lung Transplantation Guidelines for the management of pediatric heart failure

, A., Gillette, P.C., and McNamara, D.G. Supraventricular tachycardia in children: clinical features, response to treatment, and long-term follow-up in 217 patients. J Pediatr . 1981 ; 98 : 875–882 | | | , x 52 Donghua, Z., Jian, P., Zhongbo, X. et al. Reversal of cardiomyopathy in patients with congestive heart failure secondary to tachycardia. J Interv Card Electrophysiol . 2013 ; 36 : 27–32 ( [discussion 32] ) | | | Class IIa 1. Electrophysiology testing or long-term monitoring can be useful in pediatric (...) , T.S., and Läer, S. Population pharmacokinetics and dose simulation of carvedilol in paediatric patients with congestive heart failure. Br J Clin Pharmacol . 2008 ; 65 : 511–522 | | | Class IIa 1. Following adult HF guidelines, it is reasonable to consider β-blockers in symptomatic children with systemic LV systolic dysfunction, particularly if the systemic ventricle has a LV morphology. Therapy should start at a small dose and slowly up-titrate. Level of Evidence B 2. Following adult HF guidelines

2014 International Society for Heart and Lung Transplantation

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>